APA (7th ed.) Citation

Lee, P., Yang, T., Chen, K., Huang, Y., Tseng, J., Hsu, K., . . . Chang, G. (2021). Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors. Nature Portfolio.

Chicago Style (17th ed.) Citation

Lee, Po-Hsin, Tsung-Ying Yang, Kun-Chieh Chen, Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Yu-Chen Wu, Ko-Jiunn Liu, and Gee-Chen Chang. Higher CD4/CD8 Ratio of Pleural Effusion Predicts Better Survival for Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Lee, Po-Hsin, et al. Higher CD4/CD8 Ratio of Pleural Effusion Predicts Better Survival for Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Nature Portfolio, 2021.